HERBALIFE LTD. (HLF) earnings date, results and what the price requires
NYSE · SEC CIK 0001180262 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $1.33B | $-26.3M | $-0.25 | Filing |
| Mar 31, 2026 | Apr 14, 2026 | $1.32B | $61.9M | $0.57 | Filing |
| Dec 31, 2025 | Feb 18, 2026 | $1.28B | $85.4M | $0.81 | Filing |
| Sep 30, 2025 | Nov 5, 2025 | $1.27B | $43.2M | $0.42 | Filing |
| Jun 30, 2025 | Aug 6, 2025 | $1.26B | $49.3M | $0.48 | Filing |
| Mar 31, 2025 | Apr 30, 2025 | $1.22B | $50.4M | $0.49 | Filing |
| Dec 31, 2024 | Feb 19, 2025 | $1.21B | $177.9M | $1.75 | Filing |
| Sep 30, 2024 | Oct 30, 2024 | $1.24B | $47.4M | $0.46 | Filing |
What would HERBALIFE LTD. have to report for its valuation to change?
At $14.57, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -4.3% a year, to $1.25. On that path the next quarter needs diluted EPS near $0.40, against $0.42 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -4.3% | -4.3% |
| EPS needed in final year | $1.25 | $1.25 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. HLF goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.